Specific protein degradation is getting explored as an alternative technique in cancer, whereby the purely natural protein degradation procedure is co-opted for therapeutic applications. Lately made novel molecules called proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A person ligand binds to the ‘protein https://www.directivepublications.org/journal-of-clinical-breast-cancer/